Gastrointestinal (GI) and hepatic manifestations among patients hospitalized with COVID-19 were found not to be associated with increased pneumonia severity or overall mortality, according to study results in IJID Regions.
Researchers sought to determine whether hepatic and GI manifestations, specifically symptoms and biochemical findings, at time of hospital admission were associated with disease severity and outcomes among patients hospitalized with COVID-19.